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Adenosine Slows Migration of Dendritic Cells but Does Not
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We report the induction and reduction of adenosine re-
ceptor A2a and A3 mRNAs, respectively, during ma-
turation of human monocyte-derived dendritic cells.
Adenosine, an immunomodulatory molecule, is un-
stable in vitro; therefore we tested a stable agonist, 50 -
(N-ethylcarboxamido)-adenosine, to explore the e¡ect
of adenosine receptor activation on dendritic cell func-
tion. We clearly show that adenosine receptor engage-
ment a¡ects the migratory activity of dendritic cells in
three distinct settings. In human skin explant culture
experiments the emigration of epidermal and dermal
dendritic cells was diminished by the addition of 50 -
(N-ethylcarboxamido)-adenosine. In a murine contact
hypersensitivity assay 50 -(N-ethylcarboxamido)-adeno-
sine caused a reduction in the numbers of epidermal
and dermal dendritic cells arriving in the draining
lymph node. In a chemotaxis assay of human dendritic
cells in response to macrophage in£ammatory protein
3b (MIP-3b)/CCL19, adenosine caused a delay in trans-
migration. Expression of a number of molecules in-
volved in dendritic cell migration (CCR5, MIP-3b/
CCL19, and MDR-1) was reduced. Importantly, all
other features of dendritic cells tested  phenotype,
antigen uptake, cytokine production, T cell activation,
and the T cell subset induction  remained unchanged.
Dendritic cells carry antigens from the periphery to
secondary lymphoid organs, where initiation of im-
mune responses occurs. Increased adenosine release
may modulate immune responses by delaying the
encounter of antigen-loaded dendritic cells with T
cells. Key words: adenosine receptors/cell movement/cellular
immunity/chemokine receptors/chemokines. J Invest Dermatol
121:300 ^307, 2003
A
denosine is a ubiquitous endogenous purine nucleo-
side, which is released at submicromolar concentra-
tions into the extracellular environment during
metabolism (Huang et al, 1997). Under conditions
of cellular stress, e.g., in£ammation, adenosine re-
lease is augmented. Accumulation of adenosine caused by adeno-
sine deaminase de¢ciency has been shown to account for
approximately 15% of human severe combined immunode¢-
ciency disease (Buckley et al, 1997). Adenosine a¡ects most cell
types and tissues. Speci¢cally, it has been shown to exert various
e¡ects on the immune system, including anti-in£ammatory ac-
tivity through the inhibition of cytokine release by human
monocytes (Bouma et al, 1994; Link et al, 2000), inhibition of neu-
trophil degranulation in activated human blood (Bouma et al,
1996), inhibition of platelet aggregation (Soderback et al, 1991),
and modulation of lymphocyte function (Bouma et al, 1996;
Huang et al, 1997). The e¡ects of adenosine are mediated by bind-
ing to P1 nucleoside receptors.
Adenosine has been reported to induce Ca2þ transients, actin
polymerization, and chemotaxis in immature dendritic cells
(DC), whereas in mature DC cAMP levels are increased and in-
terleukin-12 (IL-12) production is decreased (Panther et al, 2001).
Currently, four adenosine-speci¢c heptahelical G-protein asso-
ciated membrane receptors are known  adenosine receptors A1,
A2a, A2b, and A3. These receptors are expressed in many cell
types (Williams and Jarvis, 2000). Under steady-state conditions,
DC reside in tissues and the few DC that leave their sites are
poorly immunogenic (Steinman and Nussenzweig, 2002). In the
presence of in£ammatory stimuli, e.g., through microbial infec-
tion, DC are promoted to migrate and to mature. Several in£am-
matory cytokines, e.g., tumor necrosis factor a (TNF-a) and IL-
1b (Cumberbatch and Kimber, 1995; Stoitzner et al, 1999), induce
activation and emigration of cutaneous DC. In addition, chemo-
kines produced in lymphatic vessels, e.g., secondary lymphoid-
tissue chemokine (Saeki et al, 1999), and/or in the lymph nodes,
e.g., macrophage in£ammatory protein 3b (MIP-3b)/CCL19
(Ngo et al, 1998; Kellermann et al, 1999), generate a chemokine
gradient to guide DC to the draining lymph nodes. DC migrate
along these chemokine gradients and during their migration they
are exposed to a variety of maturation stimuli. These stimuli re-
sult in a switch of the molecular repertoire, including receptor
molecules, chemokines, cytokines, adhesion molecules, and sig-
naling molecules, which together determine the immunogenic
activity of DC (Banchereau and Steinman, 1998; Guermonprez
et al, 2002). Here, we report that the adenosine receptors are part
of that switch, i.e., adenosine receptor A3 is markedly downregu-
lated whereas adenosine receptor A2a is upregulated when DC
are exposed to maturation stimuli in vitro.
We further studied the e¡ect of adenosine and its stable analog,
50 -(N-ethylcarboxamido)-adenosine (NECA), on DC function,
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including antigen uptake, expression of surface marker and costi-
mulatory molecules, cytokine production, migration, and activa-
tion of T cells and their subtype di¡erentiation. Exposure of DC
to adenosine or NECA selectively a¡ected the migratory capacity
of DC, but all other functions remained intact.
MATERIALS AND METHODS
Generation of monocyte-derived DC Human DC were prepared
from peripheral blood monocytes (isolated from whole blood or
leukocyte removal ¢lters) essentially as described previously (Bender et al,
1996; Romani et al, 1996; Ebner et al, 2001). Monocytes were obtained by
isolating CD14þ cells by magnetic sorting (MACS; Miltenyi Biotec,
Bergisch-Gladbach, Germany) or by depleting T cells by E-rosetting.
Brie£y, 2106 cells per well were plated in six-well tissue culture plates
in 3 ml of complete culture medium (RPMI 1640, PAN; Biotech,
Aidenbach, Germany), supplemented with 50 mg per ml of gentamycin,
10% fetal bovine serum (Biological Industries, Kibbutz Haemek, Israel,
or Seromed Biochrom, Berlin, Germany) containing 800 U per ml
granulocyte macrophage colony stimulating factor (Leukomax, speci¢c
activity 1.1106 U per mg; Novartis, Basel, Switzerland) and 1000 U per
ml IL-4 (Strathmann, Hamburg, Germany). Culture mediumwas renewed
every other day by removing 1 ml of the medium and substituting 1.5 ml
fresh medium containing 1600 U per ml granulocyte macrophage colony
stimulating factor and 1000 U per ml IL-4. On day 6 cells were cultured
for 2 d with or without (Romani et al, 1996) a de¢ned cytokine cocktail
(Jonuleit et al, 1997) consisting of TNF-a (10 ng per ml, kindly provided
by Dr G.R. Adolf, Bender, Vienna, Austria), IL-1b (2 ng per ml,
PeproTech EC, London, UK), IL-6 (1000 U per ml, PeproTech), and
prostaglandin E2 (1 mg per ml; Pharmacia & Upjohn, Buurs, Belgium) as
maturation stimulus.
For experiments we treated immature and mature DC with 75 mM
adenosine (Sigma, St. Louis, MO) or the stable analog NECA (Sigma)
for the last 48 h of DC di¡erentiation.
Microarray mRNA was isolated by a double pass over OligoTex
mRNA isolation columns (Qiagen, Valencia, CA) from total RNA of
human monocyte-derived immature and mature DCs (prepared as
described above). Total RNA was extracted using TRIZOL (Gibco BRl,
Life Technology, Paisley, UK). A comparative microarray consisting of more
than 8000 genes was performed by Genome Systems (St. Louis, MO).
Quantitative PCR analysis This was performed using real-time PCR
(ABI PRISM 7700 sequence detector, Applied Biosystems, Vienna,
Austria). Sequences for probes and primers (synthesized by Microsynth,
Balgach, Switzerland) speci¢c for single mRNA molecules were selected
using the Primer Express software (Applied Biosystems) and are listed in
Table I. For PCR the Brilliant Quantitative PCRCore Reagent Kit from
Stratagene was used. Random primed cDNAwas prepared (Superscript II
RNase H-reverse transcriptase, Life Technologies, Vienna, Austria) from
total RNA isolated from NECA-treated or untreated immature and
mature DC.
Antigen uptake Human monocyte-derived DC were suspended in
culture medium and incubated with 0.5 mg per ml £uorescence
isothiocyanate (FITC) dextran (Mr¼ 40,500, Sigma) for 30 min at 371C
or at 41C as a negative control. Cells were washed four times with ice-
cold phosphate-bu¡ered saline supplemented with 0.1% bovine serum
albumin and analyzed by £uorescence-activated cell sorting (FACS).
Flow cytometry Primary antibodies are listed in Table II. Specimens
were analyzed on a FACScalibur using CellQuest software (BD
Immunocytometry Systems, San Jose, CA).
Elisa Culture supernatants of human monocyte-derived DC were
analyzed for IL-10 and, after coculture with CD40-ligand-transfected cells
(Graf et al, 1992) for 2 d, for IL-12 (p70). Transfectants were a kind gift of
Dr R.A. Kroczek, Berlin, Germany. Cell supernatants of cocultures with
allogeneic CD45RAþ T cells (5 d) were analyzed for interferon-g and
IL-4. ELISA kits were from Pharmingen, San Diego, CA; Biosource,
Camarillo, CA; and Cytimmune, College Park, MD.
Mixed leukocyte reaction Graded doses of DC were cocultured with
2105 allogeneic bulk peripheral blood T cells or with na|«ve CD45RAþ
T cells for 6 d and proliferation was measured by 3H-thymidine
incorporation for the last 16 h (4 mCi, 148 kBq per ml of [3H]TdR
(speci¢c activity 247.9 GBq per mmol¼ 6.7 Ci per mmol; New England
Nuclear, Boston, MA)) in £at-bottomed 96-well microtiter plates
(#3072; Falcon Labware, Oxnard, CA).
Tcells were isolated from rosettes formed during the monocyte isolation
procedure (see above). CD45RAþ na|«ve T cells were enriched from this
Table I. Sequences of primers and probes used for quantitative PCR analysis
Forward primer 5030 Reverse primer 5030 FAM-TAMRA labeled probe 5030
ADORA 2a GGCCATCGCCATTGACC CACCAAGCCATTGTACCGG ACATTGCCATCCGCATCCCGC
ADORA 3 CCATCGCTGTGGACCGA TCTGTGAGTGGTGACCCTCTTG ACTTGCGGGTCAAGCTTACCGTCAGAT
CXCL9 TTGGGCATCATCTTGCTGG GGAACAGCGACCCTTTCTCA TCTGATTGGAGTGCAAGGAACCCCAGTA
CXCL10 TGAAATTATTCCTGCAAGCCAAT CAGACATCTCTTCTCACCCTTCTTT TGTCCACGTGTTGAGATCATTGCTACAATG
CXCL11 CCTTGGCTGTGATATTGTGTGC CCTATGCAAAGACAGCGTCCT CAGTTGTTCAAGGCTTCCCCATGTTCA
CCL17 GCTTCTCTGCAGCACATCCAC TGAAGTACTCCAGGCAGCACTC CAGCTCGAGGGACCAATGTGGGC
CCL18 TCTGAAACCAGCCCCCAG CTGCCGGCCTCTCTTGG CCCCAAGCCAGGTGTCATCCTCCT
CCL19 CCCCAGCCCCAACTCTG GGGATGGGTTTCTGGGTCAC CCAATGATGCTGAAGACTGCTGCCTG
CCL22 TCCTGGTTGTCCTCGTCCTC CATGTTGGCGCCGTAGG CGCTTCAAGCAACTGAGGCAGGC
CCL25 CGCCTGGACTTACCGGATC GGTAGAATATCGCAGCAGGCAG TTGCAGCTCCCGCTCACCTCCT
CXCR1 GTCCTGCCGCTGCTCATC TCGACACCGAAGCAGGGT TGGTCATCTGCTACTCGGGAATCCTGA
CXCR4 CCTGGCCTTCATCAGTCTGG TTGGCCTCTGACTGTTGGTG CGCTACCTGGCCATCGTCCACG
CCR2 GACCAGGAAAGAATGTGAAAGTGA GCTCTGCCAATTGACTTTCCTT CACAAGGACTCCTCGATGGTCGTGG
CCR5 TTGCCAAACGCTTCTGCA CGGGTGTAAACTGAGCTTGCT TTCTATTTTCCAGCAAGAGGCTCCCGA
CCR7 CCATGACCGATACCTACCTGC AGGGAAGGGTCAGGAGGAAG AACCTGGCGGTGGCAGACATCC
CCR11 CCTGATCACCAGCTGCAACAT GCGATGCTTTCTGTGACTTGG AGCAAACGCATGGACATCGCCA
TIMP-1 GTCTGCGGATACTTCCACAGG CCTGCAGTTTTCCAGCAATGA CCCACAACCGCAGCGAGGAGTT
TIMP-2a GGCGTTTTGCAATGCAGATGTAG ACAGGAGCCGTCACTTCTCTTG
TIMP-3 GCCTTCTGCAACTCCGACA TCCTTTACCAGCTTCTTCCCC CGTGATCCGGGCCAAGGTGG
MMP2 CATCATGCAAGTTCCCCGGC TGTTCAGGTATTGCACTGCCA TCGCCCCCAAAACGGACAAAGA
MMP9 CGCAGACATCGTCATCCAGT CCGTCGAAGGGATACCCG TGGTGTCGCGGAGCACGGAG
MDR-1 CACGTCAGCCTTGGACACAG CGACCTTTTCTGGCCTTATCC AAGCGAAGCAGTGGTTCAGGTGGCTC
UPA AAGATCCGTTCCAAGGAGGG GGGCAGGCAGATGGTCTGTA TGTGCGCAGCCATCCCGG
UPAR GACCTCTGCAGGACCACGA TTTTCTCCACCAGCTCCAGC CGTGCGCTTGTGGGAAGAAGGAGAA
18s CCATTCGAACGTCTGCCCTAT TCACCCGTGGTCACCATG ACTTTCGATGGTAGTCGCCGTGCCT
aquantitative PCRwas performed using the Sybr Green PCR kit (PE Biosystems, UK) according to the manufacturer’s protocol under the same conditions as described
for real-time PCR in Materials and Methods.
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population using negative selection by panning with antibodies against
CD8, CD16, CD45RO, CD56 (Becton-Dickinson Immunocytometry
Systems, San Diego, CA), and CD14, CD19 (BD-Pharmingen, San Diego,
CA). FACS staining of the enriched population with anti-CD45RA
showed an average of 80% positive cells.
Skin organ culture Human skin organ cultures were performed as
described previously (Pope et al, 1995; Romani et al, 1997). Skin explants
were prepared with an 8 mm punch from split-thickness skin (0.3 mm)
and cultured on 1.5 ml culture medium in 24-well plates (one explant per
well) for the indicated times at 371C. At least six explants (i.e., six wells)
were pooled for each experimental condition. Cells that had emigrated into
the culture medium were harvested, counted in the hemocytometer, and in
some experiments further evaluated phenotypically using anti-CD208/DC-
LAMP as a marker for mature DC and anti-CD207/Langerin (both from
Beckman-Coulter, Fullerton, CA) as a likely indicator for epidermal DC.
In vivomigration assay For these experiments two groups of mice were
used, each consisting of three animals. The control group received 50 ml of
0.1% bovine serum albumin/phosphate-bu¡ered saline intradermally into
the pinnae of the ear, the experimental group 50 ml of 75 mMNECA. After
90 min right ears were treated with 20 ml of vehicle (acetone:olive oil, 4:1)
and left ears with 1% of the contact allergen 2,4,6-trinitro-1-
chlorobenzene picryl chloride (TNCB) (Kodak Eastman, Rochester, NY).
Epidermal and dermal sheets were prepared 24 h and 48 h later by
separation with ammonium thiocyanate (Merck, Westchester, PA), ¢xed
with acetone, stained with anti-major histocompatibility complex (MHC)
class II (2G9 FITC-conjugated, Pharmingen), and analyzed for Langerhans
cells in the epidermis and for the presence of lymphatic vessels ¢lled with
emigrating DC in the dermis. The number of Langerhans cells was
determined under the microscope using 40 objective lenses and a
calibrated grid (at least 20 ¢elds). Alternatively, cells from auricular lymph
nodes were prepared by collagenase digestion (0.2 mg per ml Collagenase
P, Applied Biosystems, Foster City, CA) and counted in the hemo-
cytometer. Cell suspensions were stained with anti-Langerin (929F3, rat
IgG2, kindly provided by S. Sealand, Dardilly, France) followed by FITC-
labeled antirat Ig (Pharmingen) as a likely indicator of the number of
immigrated Langerhans cells (Valladeau et al, 2002). For total numbers of
DC in the lymph node, cells were labeled with phycoerythrin-conjugated
anti-CD11c monoclonal antibodies (Pharmingen). Absolute numbers of
DC per lymph node were determined on the basis of FACS analyses and
hemocytometer cell counts.
Transmigration assay Mature human monocyte-derived DC (105) in
0.5 ml culture medium with or without 75 mM NECA/adenosine were
placed into the upper chamber of a transwell (8 mm pore size transwell
insert, Costar Cat. No. 3422, Corning, NY). The lower chamber
contained 1 ml of culture medium supplemented with 0.3 mg per ml
MIP-3b/CCL19 (R&D Systems, Minneapolis, MN) or 0.1 mg per ml
MIP-1a/CCL3 (R&D Systems). Transmigrated cells were counted after
the indicated time intervals in the hemocytometer.
RESULTS
Adenosine receptors A2a and A3 are di¡erentially expressed
during DC maturation Comparing gene expression in
immature versus mature human monocyte-derived DC in a
microarray format, we found the adenosine receptors A2a and
A3 to be di¡erentially regulated during maturation. We
con¢rmed these data by quantitative PCR and found an
approximately 40-fold change during maturation, i.e., A2a was
increased approximately 40-fold whereas A3 was reduced
approximately 40-fold (Fig 1). In contrast, expression of mRNA
coding for the other known adenosine receptors, A1 and A2b,
was very low and did not change with maturation (data not
shown).
Upregulation or downregulation of receptors usually
represents a de¢ned change in cell function. We therefore
investigated the e¡ect of the receptor ligand on DC. The
physiologic ligand adenosine is unstable in vitro (Williams and
Jarvis, 2000). We therefore used the stable agonist NECA in all
experiments except for the transmigration assays, where short
incubation times were required. NECA, like adenosine, binds to
all four known adenosine receptors. Both compounds have been
shown to be e¡ective at similar concentrations onTcell activation
and expansion (Huang et al, 1997).
NECA treatment does not alter DC phenotype and
function First, we checked that ligand treatment would not
a¡ect viability of human monocyte-derived DC. Concentrations
of adenosine in extracellular £uids are reported to be within the
range 0.4^200 mM (Huang et al, 1997; Meade et al, 2001). Addition
of 10^200 mM NECA to human monocyte-derived DC during
the last 48 h of di¡erentiation/maturation did not cause any
toxic e¡ect as determined by trypan blue exclusion (data not
shown). Thus, an intermediate dose of 75 mM was used in all
subsequent experiments. Next, we evaluated the e¡ects of
adenosine receptor activation on a variety of parameters known
to be critical for DC function. Addition of NECA during the
last 48 h of human monocyte-derived DC di¡erentiation did
not alter the capacity of immature DC to take up FITC-labeled
dextran (Fig 2a). Furthermore, comparing NECA-treated with
untreated DC, no changes were found either on immature or on
mature DC with respect to the costimulatory molecules CD40,
CD80, and CD86, as shown in Fig 2(b). In addition, no changes
in the expression pro¢le of other surface markers such as CD18,
CD11a, CD11c, CD83, HLA-ABC, and HLA-DRwere observed
(data not shown). Similarly, IL-12 and IL-10 production by DC,
Table II. Monoclonal antibodies used for phenotypic analysis
by £ow cytometry
Speci¢city Clone/Name Ig class Source
CD40 5C3 Mouse IgG1 BD-Pharmingena
CD80 L307.4 Mouse IgG1 BD-Pharmingena
CD86 IT2.2 Mouse IgG2b BD-Pharmingena
CD18 6.7 Mouse IgG1 BD-Pharmingena
CD11a HI111 Mouse IgG1 BD-Pharmingena
CD11c KB90 Mouse IgG1 DAKOb
HLA-ABC G46-2.6 Mouse IgG1 BD-Pharmingena
HLA-DR G46-6 Mouse IgG2a BD-Pharmingena
CD45RA HI100 Mouse IgG2b BD-Pharmingena
CD83 HB-15a Mouse IgG2b Immunotech/Coulterc
CCR2 48607.211 Mouse IgG2b R&D Systemsd
CCR5 CTC5 Mouse IgG1 R&D Systemsd
CCR7 2H4 Mouse IgM BD-Pharmingena
aBD-Pharmingen, San Diego, CA.
bDAKO/Cytomation A/S, Glostrup, Denmark.
cImmunotech/Coulter/Beckman, Fullerton, CA.
dR&D Systems Europe, Abingdon, UK.
Figure1. mRNA levels of the A2a and A3 adenosine receptors. To
verify the results of the microarray the mRNA levels coding for the ade-
nosine receptors were determined by real-time PCR using primers and
probe as indicated in Table I. Upregulation and downregulation during
maturation of A2a and A3, respectively, was found on all four DC prepara-
tions tested. Columns represent mean values7standard deviations. i DC,
immature DC; m DC, mature DC.
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as analyzed in supernatants of CD40-ligand-stimulated DC or
unstimulated DC, respectively, appeared unchanged with NECA
treatment (data not shown). Finally, the T cell stimulatory
capacity of DC as measured by mixed leucocyte reaction (Fig
2c) was not a¡ected by NECA treatment, and when cytokine
pro¢les of T cells activated by NECA-treated DC were
monitored, they were indistinguishable fromT cells activated by
untreated DC (data not shown), indicating that no shift from
TH1 towards TH2 subtypes had occurred.
Migration of DC from skin explant cultures is delayed by
NECA In cultures of whole human skin explants, we
monitored the migratory behavior of resident DC in skin under
the in£uence of NECA. Addition of NECA inhibits the
emigration of DC in this system (Fig 3). This e¡ect is more
pronounced after 24 h than after 48 h of incubation. Most of
the emigrated DC (83%^95%) are of the mature phenotype
as monitored by DC-LAMP expression, in both the absence
and presence of NECA. Langerin, a molecule speci¢c for
Langerhans cells, is expressed by 11%^34% of the emigrated
DC both with and without addition of NECA (data not shown).
Immigration of Langerhans cells and dermal DC from the
periphery into the draining lymph nodes upon
immunostimulation is delayed by NECA To further extend
these experiments we studied the e¡ect of NECA on the
migration of DC in vivo.We used the contact allergen TNCB to
induce a contact sensitivity reaction in murine ear skin, which
involves the migration of Langerhans cells to the draining
lymph nodes.When NECAwas injected subcutaneously 90 min
prior to TNCB application, the emigration of Langerhans cells
out of the epidermis was not a¡ected, as shown by similar
numbers of Langerhans cells remaining in the epidermis 48 h
after TNCB/NECA treatment (Fig 4a). Similarly, migration
into the dermis appeared unchanged when assessed by
immuno£uorescence staining with MHC class II (data not
shown). When the numbers of DC arriving in the draining
lymph node 48 h after stimulation are quantitated, however, we
¢nd a pronounced reduction in CD11cþ (Fig 4b) and Langerinþ
DC (Fig 4c) in the presence of NECA.
Transwell migration of DC in response to MIP-3b/CCL19
is delayed by NECA and adenosine Adenosine receptors
are widely expressed. In order to exclude the participation of
other cells in the e¡ects of adenosine receptor activation on DC
function, we used a transmigration assay for chemotaxis of
human monocyte-derived DC. As chemoattractants in this assay,
we used MIP-1a/CCL3 for immature DC (Sozzani et al, 1995) and
MIP-3b for mature DC (Sallusto et al, 1998a). In response to MIP-
3b, a reproducible and signi¢cant e¡ect of NECA and adenosine
on mature DC migration was observed; i.e., at early time points
fewer DC transmigrated when they had been exposed to NECA
(Fig 5a) or adenosine (Fig 5b). Using both NECA or adenosine,
however, the numbers of transmigrated cells were not di¡erent
after 4 h (data not shown), indicating a delay in migration rather
than a complete inhibition. For e⁄cient migration of immature
DC towards MIP-1a/CCL3 a maturation stimulus was necessary
at the onset of the transwell migration assay (data not shown).
Yet, the migration of immature DC in response to MIP-1a/
CCL3 was not a¡ected by the addition of NECA or adenosine.
Figure 2. Antigen uptake, expression of costimulatory molecules,
and Tcell activating capacity of DC treated with NECA for the last
48 h of di¡erentiation/maturation remain unchanged. (a) Antigen
uptake was monitored by measuring £uorescence intensity of immature
DC incubated with 0.5 mg per ml FITC-dextran for 30 min at 371C. Thin
lines indicate £uorescence intensity after incubation at 41C (negative con-
trol). (b) Histograms show staining of DC populations gated in light scatter
plots. Thin lines indicate staining by isotype-matched irrelevant control
antibodies. CD40, CD80, and CD86 expression levels are enhanced during
maturation but not altered by treatment with NECA. (c) A mixed leuko-
cyte reaction was performed with DC generated in the absence or presence
of NECA as indicated: &, immature untreated DC; ’, mature
untreated DC; n, immature NECA-treated DC; m, mature
NECA-treated DC. DC (stimulators) were cocultured in graded doses as
indicated with 1.5105 allogeneic T cells for 6 d. Proliferation was mea-
sured by H3-thymidine incorporation in counts per minute (cpm). Back-
ground proliferation of Tcells alone was 300 cpm. Each experiment shown
is representative of four.
Figure 3. Emigration of DC from skin explants. Standardized pieces
of human skin were prepared with an 8 mm punch from split-thickness
skin (0.3 mm). These explants were £oated on 1.5 ml culture medium or
culture medium containing 75 mM NECA in 24-well plates (one explant
per well) for 24 h (white bars) or 48 h (black bars) at 371C. At least six ex-
plants (i.e., six wells) were pooled for each experimental condition. Cells
that had emigrated into the culture medium during this time were har-
vested and counted. DC numbers emigrated in culture medium alone were
set equal to 100%. Three di¡erent experiments are shown (1, 2, 3).
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Expression level of molecules involved in DC migration To
¢nd possible explanations for the impaired migratory capacity of
DC treated with NECA we monitored the mRNA expression
pro¢le of a panel of chemokines, chemokine receptors, and
other molecules reported to be related to DC migration (Table I)
and, if possible, con¢rmed changes of the protein level.
The expression of MIP-3b mRNA, a chemokine produced by
DC but also the major chemotactic factor for mature DC
(Sallusto et al, 1998a), was dramatically decreased by the addition
of NECA to DC during their maturation period (Fig 6.Aa). The
expression levels of other DC-derived chemokines (CXCL9/mig,
CXCL10/IP10, CXCL11/I-TAC (Hamilton et al, 2002; Padovan
et al, 2002), CCL17/TARC, CCL18/PARC, CCL22/MDC
(Sallusto et al, 1998b; Vissers et al, 2001), CCL25/TECK (Vicari
et al, 1997) remained unchanged (data not shown).
CCR2, the receptor for MCP-1, is regulated during DC
maturation (Cyster, 1999). mRNA expression was found to be
reduced in DC treated with NECA. The mRNA expression
level was very low, however. Presumably, this accounts for the
fact that CCR2 could not be detected on the surface of
monocyte-derived DC (data not shown). The receptor for MIP-
1a/CCL3, CCR5, was reduced by NECA both at the mRNA
level (Fig 6.Ba) and at the protein level, as shown by FACS
analysis (Fig 6.Bb). The receptors for MIP-3b/CCL19, CCR7
(Cyster, 1999), and CCR11 (Fig 6.Cb) are expressed on
immature and mature DC, respectively. Surprisingly, mRNA
levels of these receptors (Fig 6.Ca, b) were not a¡ected by
NECA treatment. At the protein level we found a small
(E10%) but consistent decrease in CCR7 expression, as shown
by FACS analyses (Fig 6.Cc).
The mRNA coding for the multidrug resistance protein
MDR-1 (p-glycoprotein), reported to be essential for emigration
of skin DC (Randolph et al, 1998), was signi¢cantly reduced in
immature DC treated with NECA. The mRNA levels coding
for additional molecules known to be involved in DC
migration, such as matrix metalloproteinases 2 and 9 (Ratzinger
et al, 2000; Osman et al, 2002) and their inhibitorsTIMP1,TIMP2,
and TIMP3 (Osman et al, 2002), and the urokinase plasminogen
activator and its receptor (Ferrero et al, 2000), were not
signi¢cantly changed by the addition of NECA (data not
shown).
Figure 4. Langerhans cell emigration from murine ear skin after
application of contact allergen (TNCB).TNCB or vehicle (acetone:olive
oil) were applied epicutaneously on the right and left ear, respectively. Mice
were injected intradermally 90 min before the allergen application either
with phosphate-bu¡ered saline or with NECA. Epidermis and lymph
nodes were analyzed 48 h thereafter. Three independent experiments are
shown (m, ’, E). (a) Epidermal sheets were prepared, and Langerhans
cells were visualized with anti-MHC class II antibodies and counted. (b),
(c) Mice were sacri¢ced, the auricular lymph nodes were removed, and cell
suspensions were prepared. After staining with anti-CD11c antibodies to
detect all DC (b) or anti-Langerin antibodies to detect immigrated Langer-
hans cells (c), positive cells were determined on the basis of FACS analysis.
Although Langerhans cells emigrate out of the epidermis to the same ex-
tent with and without prior injection of NECA in response to the applica-
tion of TNCB (a), the same treatment led to reduced numbers of DC
arriving in the draining lymph nodes (b, c).
Figure 5. Migration of DC in response to MIP-3b/CCL19. In a trans-
well assay the migratory activity of mature DC was monitored over a per-
iod of 60 min (NECA) or 90 min (adenosine). Addition of NECA (a) or
adenosine (b) immediately before starting the experiment (’) caused a de-
lay of migration compared to controls (m). One out of four experiments
with similar results is shown.
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DISCUSSION
In£ammation stimulates adenosine release into the extracellular
space. One postulated consequence is protection of tissues from
immunopathologic injury (Linden, 2001). The underlying me-
chanisms are not well understood; however, modulation of in-
nate immunologic processes has been attributed to adenosine.
The di¡erential regulation of the receptors for adenosine on
DC during maturation (Fig 1 and Panther et al, 2001) indicates
that these receptors might play a role in regulating DC function.
Our results indicate that adenosine/NECA treatment has a selec-
tive e¡ect on DC migration, but does not a¡ect other aspects of
DC maturation. DC migration was assessed in three di¡erent, in-
dependent experimental settings. First, human skin explant cul-
tures revealed a reduced emigration of DC from skin (Fig 3).
Furthermore, our in vivo experiments carried out in a mouse
model of contact sensitivity con¢rmed these ¢ndings. The num-
ber of DC arriving in the skin-draining lymph node was reduced
(Fig 4b, c). Interestingly, the number of Langerhans cells remain-
ing in the epidermis 48 h after sensitization was not higher in
NECA-treated mice compared to control mice (Fig 4a). This in-
dicates that Langerhans cells leave the epidermis after stimulation
with a contact sensitizer, regardless of NECA treatment, but are
retained somewhere along their route from the skin to the lymph
nodes. A similar situation was previously reported for CCR2-
null mice. In these animals, Langerhans cell density in the epider-
mis was normal and their ability to migrate into the dermis was
intact. DC migration to the draining lymph nodes was markedly
impaired, however, as shown by an accumulation of DC in the
dermis (Sato et al, 2000). In contrast, our experiments in the con-
tact sensitivity mouse model revealed no enrichment of MHC
class IIþ cells in the dermis, indicating a distinct mechanism for
the NECA-induced delay in DC migration.When we examined
the expression levels of CCR2 on human monocyte-derived
DC, we found low expression on immature DC, which was
further decreased upon maturation. Addition of NECA during
the last 48 h of di¡erentiation of immature DC led to a down-
regulation of the mRNA coding for CCR2. At the protein level,
however, CCR2 could not be detected on either DC population,
presumably due to low expression (Cyster, 1999). Thus, our data
suggest an involvement of CCR2 in the observed e¡ects of ade-
nosine.
Figure 6. Expression levels of molecules involved in DC migration.mRNA expression levels as measured by real-time PCR (for primers and probes
refer toTable I), ELISA and FACS analyses are shown. One out of four experiments with similar results is shown: (6.A.a) MIP-3b/CCL19 mRNA; (6.A.b)
MIP-3b/CCL19 protein secretion. Both are reduced by NECA treatment in mature DC. The mRNA expression level (6.B.a) and the surface expression
(6.B.b) of CCR5 in NECA-treated immature DC are reduced to approximately 50%. mRNA levels of CCR7 (6.C.a) and CCR11 (6.C.b) and surface
expression of CCR7 (6.C.c) are shown. (6.C.c) The dotted line shows staining with an isotype-matched irrelevant antibody, the thin line shows staining of
NECA-treated mature DC, and the bold line shows staining of untreated mature DC. mRNA levels are not signi¢cantly changed by NECA treatment.
Surface expression was minimally (o 10%) but reproducibly reduced. (6.D) The mRNA level of MDR-1 in immature DC is reduced by NECA treatment
to approximately 50%.
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Other regulatory molecules known to control the induction of
DC migration include MIP-1a/CCL3 and its receptor CCR5
(Vanbervliet et al, 2002).We report here that CCR5 expression is
downregulated both at the mRNA level and the protein level in
immature DC (Fig 6.C). Although the migration of NECA-trea-
ted immature monocyte-derived DC in response to MIP-1a/
CCL3 is not impaired in transwell migration assays, the NECA-
induced delay in skin DC emigration out of human skin explants
may at least partially be due to reduced expression of CCR5.This
is in accordance with Sato et al (2000), who reported a decreased
emigration of Langerhans cells from skin explants in CCR5-null
mice.
Moreover, MIP-3b/CCL19 has been described as a major che-
moattractant for mature DC (Sallusto et al, 1998a). A plausible ex-
planation for the delay in DC migration after adenosine exposure
would be a decrease in CCR7 and CCR11, the receptors for
MIP-3b/CCL19. mRNA expression levels of both receptors re-
mained essentially unchanged, however, in our experiments. Yet,
FACS staining revealed a small but consistent reduction in
CCR7 expression (Fig 6.B) in the presence of NECA, which
may not fully su⁄ce to explain the delay in DC migration.
On the other hand, downregulation of MIP-3b/CCL19 expres-
sion was a major e¡ect of NECA on DC in our experiments. Pre-
viously, plt mice, de¢cient in both MIP-3b/CCL19 and CCL21,
have been shown to mount delayed primary T cell responses
(Mori et al, 2001). Functionally, the production of MIP-3b/
CCL19 by mature DC has been postulated to accentuate the gra-
dient generated by MIP-3b/CCL19 within lymph nodes to attract
newly arriving DC (Sallusto et al, 1999). This could explain the
reduced numbers of DC arriving in the lymph nodes as shown
in our mouse model of contact sensitivity (Fig 4b, c). Reduced
numbers of emigrated DC were also found in the skin explant
model, however, which solely simulates the initial part of DC
migration from the skin. Staining for MIP-3b/CCL19 in murine
epidermis and dermis was negative (unpublished data). Therefore,
the adenosine-induced reduction of MIP-3b/CCL19 cannot ac-
count for the delay in DC migration from skin explants. The in-
hibitory e¡ect of NECA on the MIP-3b/CCL19 expression of
DC together with the impaired migration in response to MIP-
3b/CCL19 may indicate an additional role of DC-derived MIP-
3b/CCL19 for DC^T cell interactions and/or localization of DC
within T cell zones of lymphoid organs.
For the delayed migration of NECA-treated DC, however,
other mechanisms, in addition to decreased MIP-3b/CCL19 pro-
duction, are likely to play a role.We therefore tested the in£uence
of NECA on the expression levels of other molecules known to
play a role in DC migration.We found no signi¢cant changes in
mRNA levels coding for matrix metalloproteinases 2 and 9 and
their inhibitors TIMP1,TIMP2, and TIMP3, or plasminogen ur-
okinase protein and its receptor. The mRNA expression level of
MDR-1 on immature DC, however, was reduced in the presence
of NECA (Fig 6.D). It has been shown that blocking of MDR-1
inhibits the emigration of Langerhans cells from the epidermis,
but maturation remains unchanged (Randolph et al, 1998). The
mechanism of this e¡ect is still unclear. Recently an impaired mi-
gration of DC to lymph nodes has been shown in MRP1-de¢-
cient mice in a model of FITC-induced contact sensitivity
(Robbiani et al, 2000). MRP1 is a family member of the multi-
drug resistance associated proteins known to be involved in the
migration of DC into a¡erent lymphatic vessels. In mice lacking
MRP1, DC are retained in the epidermis and dermis. This was
explained by an abnormal chemotaxis to MIP-3b/CCL19, which
in turn was due to a lack of leukotrienes transported via multi-
drug resistance proteins. In our model, DC are not retained in
the epidermis and dermis, so that changes in MRP1 are not likely
to be a molecular basis for the NECA-induced delay in DC mi-
gration. The decrease in MIP-3b/CCL19 and MDR-1 expression
that we report here for human monocyte-derived DC, however,
could still point to a possible e¡ect of NECA on chemotaxis
mediated by molecules transported by MDR1.
Our ¢ndings clearly demonstrate that adenosine/NECA selec-
tively impairs the migratory capacity of DC. Thus, we conclude
that the adenosine receptors A2a and A3, which are di¡erentially
regulated on immature and mature DC, are important for DC
migration. Furthermore, we identi¢ed alterations in a number
of molecules known to be involved in DC migration. Together,
these molecules may coordinately delay DC migration in the pre-
sence of adenosine/NECA.The protective properties of adenosine
in the context of tissue injury during in£ammation (Linden,
2001) can at least be partly attributed to its inhibitory e¡ect on
DC migration. Adenosine release could counterbalance in£am-
matory stimuli by delaying the arrival of mature DC to lymph
nodes, thereby impairing the initiation of immune responses.
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